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Abstract
Malaria resulting from Plasmodium falciparum infection is a major cause of human suffering and
mortality. Red blood cell (RBC) deformability plays a major role in the pathogenesis of malaria.
Here we introduce an automated microfabricated “deformability cytometer” that measures
dynamic mechanical responses of 103–104 individual RBCs in a cell population. Fluorescence
measurements of each RBC are simultaneously acquired, resulting in a population-based
correlation between biochemical properties, such as cell surface markers and dynamic mechanical
deformability. This device is especially applicable to heterogeneous cell populations. We
demonstrate its ability to mechanically characterize a small number of P. falciparum-infected (ring
stage) RBCs in a large population of uninfected RBCs. Furthermore, we are able to infer
quantitative mechanical properties of individual RBCs from the observed dynamic behavior
through a dissipative particle dynamics (DPD) model. These methods collectively provide a
systematic approach to characterize the biomechanical properties of cells in a high-throughput
manner.
Introduction
RBC deformability may be pathologically altered due to inherited genetic disorders (e.g.
sickle cell anemia and hereditary spherocytosis), and both non-infectious 1 and infectious 2
diseases. Decreased human RBC deformability is both a cause of and biomarker for disease
states 3. Malaria, a disease threatening approximately 2.2 billion people globally, and
causing about 250 million clinical episodes and 1 million deaths annually 4, is an important
example of an infectious disease process that drastically decreases RBC deformability. The
most virulent human malaria parasite, Plasmodium falciparum, invades and develops within
RBCs, and transitions through morphologically-distinct ring, trophozoite and schizont stages
during the 48-hour maturation period within the RBC 5. While ring stage parasite-infected
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RBCs are less deformable than uninfected RBCs by only several-fold, late (trophozoite and
schizont) stage parasite-infected RBCs are stiffer by a factor of up to 50 or more 2, 6.
Altered RBC deformability has important implications for disease pathophysiology. In
traversing a blood capillary, the biconcave disc-shaped RBC must deform dramatically, as
its unconstrained diameter exceeds that of a capillary. The reticuloendothelial system (RES)
plays an important role in eliminating parasite-infected RBCs from the circulation, and
achieves this in part by sensing increases in RBC membrane rigidity 7. While the RES can
efficiently deplete rigid late stage parasite infected RBCs from the circulation, the less rigid
ring-stage-parasite infected RBCs are inefficiently removed 7. Thus, ring but not late stage
parasite infected RBCs can be found in the peripheral circulation and measured for
diagnostic purposes. Additionally, increased stiffness of late stage parasite infected RBCs,
together with their enhanced adherence to endothelial cells, leads to their sequestration in
the microvasculature of various organs. This is believed to be a key event precipitating
potentially fatal malaria complications such as cerebral malaria 8. As such, characterizing
parasite infected RBC deformability in a quantitatively rigorous manner will be important
for better understanding the basic mechanisms underlying host clearance of parasite-infected
RBCs and overall malaria pathophysiology. To this end, robust laboratory methods for
quantitatively analyzing cell deformability in high throughput over heterogeneous cell
populations and at low cost are desirable.
Existing high-throughput methods for analyzing and quantifying cell deformability typically
overlook cell population heterogeneity, and quantitative single-cell measurements are
generally labor and skill-intensive. While methods for studying cell biochemical
characteristics (e.g. fluorescence-activated cell sorting (FACS)) are common, there is a
paucity of techniques for investigating dynamic mechanical properties of cells. Commonly
used methods for studying RBC deformability include filtration 9 and laser diffraction
ellipsometry 10, which both measure bulk properties of a cell population. Therefore, these
methods are not applicable in situations where the target cells constitute a small fraction of
the entire cell population 11, as would routinely be the case for minimally processed
laboratory or clinical samples containing P. falciparum-infected RBCs. Furthermore, past
work involving filtration typically involves a sheet of pores, resulting in only a single pore-
transit measurement for each cell 11–14.
Examining cells individually is an important strategy for characterizing inherently
heterogeneous cell populations. Micropipette aspiration is one such method, and it has been
applied to quantitatively study infected RBC deformability 15. However, it is laborious and
limited in its throughput 16. More recent techniques include atomic force microscopy 17,
optical stretching 18, and optical tweezers 19. Still, these methods are labor-intensive,
expensive, and time-consuming. Furthermore, the relevance of these essentially static
mechanical responses to what the RBC experiences in the circulation of a living organism
may be limited.
Improvements in microfabrication techniques have enabled the creation of pores comparable
in size to the smallest human capillaries 20. Studies using these devices are similar in nature
to those involving micropipette aspiration 21, 22. However, less time and effort are required
due to the well-controlled dimensions of the pores and the ability to simultaneously examine
many cells. Furthermore, studies using microfabricated pores arguably simulate more
closely the movement of individual RBCs through capillaries in vivo. Along these lines, a
microfabricated device similar to a single micropipette aspirator has been created to examine
the rigidity of P. falciparum infected RBCs 22. However, this single micropore design
significantly limits overall throughput, and cell-cell interactions resulting in clogging at the
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pore inlet complicate obtaining quantitative and statistically significant data for cell
populations.
Here we introduce an automated, microfabricated ‘deformability cytometer’ that measures
dynamic mechanical responses of about 103–104 individual RBCs in a population.
Fluorescence measurements on each RBC are simultaneously acquired, resulting in a
population-based correlation between biochemical properties (e.g. cell surface markers) and
dynamic mechanical deformability. Significantly extending past work 20, 22, we propose a
novel method relying on low Reynolds number fluid mechanics to evaluate the effect of
entrance architecture on the sensitivity of cell deformability measurements. Custom software
was written to automate video processing and facilitate easy analysis of thousands of RBCs,
which is rarely accomplished in microfluidic systems. This higher throughput enabled us to
measure statistically significant differences in deformability between two cell populations.
Lastly, a Dissipative Particle Dynamics (DPD) model was built to translate the experimental
measurements into quantitative data describing the mechanical properties of individual
RBCs. This is the first study to systematically design and implement a microfluidic device
capable of measuring cell deformability in high throughput and is sufficiently simple and
inexpensive such that it can potentially be tailored for use with many different cell types.
Results
Our device design involves periodically spaced, triangle-shaped pillars. The gaps between
these pillars result in well-controlled constrictions for RBCs to pass. The height of the
device was set to 4.2 µm to encourage RBCs to assume a flat orientation before entering
each constriction. This height, in addition to filters at the reservoirs (10 µm diameter pillars
spaced 10 µm apart), prevents white blood cells from entering the device, permitting diluted
whole blood to be used directly. As in any of these types of microfluidic devices, this device
will eventually clog after a long term operation. However, the device can be operated until
approximately 104 cells are analyzed before significant clogging occurs, resulting in the
ability to generate statistically-significant results using a single device. Further increasing
the parallelism of the device will result in the ability to expand the number of cells analyzed
by 1–2 orders of magnitude. Still, in any design where objects are forced to enter a pore
clogging is inevitable; in another approach, we forced cells to travel at an oblique angle to
slits, which avoids the clogging problem 23. In our experiments, the concentration of RBCs
is sufficiently low such that there is minimal interaction between cells and that transit times
are independent. The constrictions in parallel across the width of the channel allow higher
throughput, and the constrictions in series along the length of the channel enable repeated
measurements of the same cell, increasing precision. Typically, the velocity of the cell is
tracked across 10 such constrictions. Figure 1A and B illustrate the device design and
demonstrate infected and uninfected RBCs moving at different velocities.
In past studies involving microfabricated pores, there has not been a determined effort to
examine the influence of the pore shape on the ability of a cell to enter. For example, some
studies use 90-degree angles for the walls of the pores 20, while others use angled or curved
entrances 21, 22. In addition, most previous studies rely on the passage of many cells through
a single pore, rendering the device susceptible to clogging and other confounding factors
during the critical trapping and escape process at the bottleneck. These differing shapes
naturally leads to the question of whether the geometry of constriction affects the amount of
force required for cell herniation and traversal for openings of the same eventual cross-
sectional area. Given the complicated nature of a cell’s deformation process through the
pore, we believe it may be possible to determine an optimized geometry ideally suited for
“deformability selection.”
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To address these questions, we built a device to compare pairs of pore entrance geometries
(Figure 1A). In this device are two channels in parallel with pores of different rates of
constriction. According to low Reynolds number laminar flow, the forward and backward
flow velocities and resistances will be identical 24. When we introduce low concentrations of
cells, we are able to simultaneously observe control and experiment in the same microscope
field of view. The difference in velocity of cells moving in the two channels indicates the
role that entrance effects play in cell deformation through the pores with different entrance
geometries, as confounding effects caused by temperature 19, cell age 25, buffer
conditions 26, pressure, and device variability are obviated.
Verification of indistinguishable fluid velocities in two channels
To verify indistinguishable fluidic resistance in, and flow rate through, the two parallel
channels, we introduced 200 nm non-deformable polystyrene beads into the fluid to track
velocity. In the range of pressures and fluid velocities that are relevant both physiologically
and in our experiments, we found that there were no statistically significant differences in
bead velocity through the channels (Figure 2). The spread in bead velocities is mostly
attributable to non-constant fluid velocities across a cross section of the channel, due to the
viscous nature of the fluid.
DPD simulations confirmed this result. The difference in fluid flow velocity was found to be
less than 0.3%, confirming that the fluidic resistance does not depend on the orientation of
the obstacles. Streamlines were also examined to confirm almost complete reversibility of
the flow.
Effect of fluid velocity and obstacle orientation on velocity of RBCs
We performed all of the experiments using RBCs diluted to approximately 1% hematocrit.
At high hematocrit, cell-cell interactions would dominate in the channels, as fluidic
resistances and velocities would be affected by nearby cells. However, at very low
hematocrit, experiments would take an unreasonably long time to run. We found that at ~1%
hematocrit, cell-cell interactions were negligible and approximately 1000 cells could be
analyzed in 10 minutes.
At all of the pressure gradients, RBCs exhibited faster velocity in the channel with
converging entrance geometries (Figure 3A). On average, RBCs traveled 25.5 % slower in
the channels with diverging geometries. The large standard deviation of velocities is
consistent with experimental results presented by others 20. Consistent with the results of
Brody et al., the velocity is independent of projected cell size and is confirmed by our
computational simulations. The large variation in velocity may be caused by the increasing
stiffness of the RBCs over their 120-day lifespan.
Effect of RBC stiffness on velocity through different constriction geometries
Treatment with increasing concentrations of glutaraldehyde for a limited period of time
results in cells of increased stiffness 27. At concentrations of glutaraldehyde less than
0.002% and treatment for 30 minutes, more than 95% of the RBCs moved through the
device. As we increased the glutaraldehyde concentration in the treatment solution, RBCs
became progressively stiffer. As shown in Figure 3B, there is an inverse correlation between
the degree of artificial stiffening and the velocity of the RBCs through the channels. At a
glutaraldehyde concentration greater than 0.003%, the majority of RBCs became
immobilized toward the entrance of the device. These experiments demonstrate that
decreased deformability alone can cause RBCs to travel with slower velocity in this device,
as cell shape and size are preserved during glutaraldehyde treatment27.
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Deformability of late ring-stage P. falciparum-infected RBCs
We performed this set of experiments using late ring-stage P.falciparum-infected RBCs that
were transfected with a gene encoding green fluorescent protein (GFP) (Figure 4). It is
believed that treatment with cell dyes influences the deformability of the cells 28. By using
cells that express GFP, we overcome this concern. Our image analysis program tracked a
shadow without a bright dot inside as an uninfected RBC and a shadow with a bright dot
inside as an infected RBC. Around 1000 RBCs were tracked for each pressure gradient. The
parasitemia in this set of experiments was around 1–2%. In all of these experiments, we
observed negligible pitting, expulsion of the parasite from the RBC.
We determined that optimal pressure gradients for device operation are around 0.24 and 0.37
Pa/µm. For both the converging and diverging geometries, at pressure gradients of 0.24 and
0.37 Pa/µm, infected RBCs exhibited lower average velocities than uninfected RBCs. A p-
value less than 0.01 at these pressure gradients leads us to conclude that the mean velocities
for the infected and uninfected cells are different with statistical significance. These results
are consistent with those involving micropipette aspiration 15. In those experiments, ring-
stage infected RBCs required around 1.5–2 times the pressure and around 1.5 times the time
to enter single pipette pores of around 3–3.5 µm. At higher pressures, mean velocities of
infected and uninfected RBCs moving through the device converged. At a pressure gradient
of 0.48 Pa/µm, uninfected and infected RBCs moved through the converging geometry at
approximately the same velocity (about 50 µm/s).
In Figure 4B, we show that the diverging geometry is better able to accentuate differences in
deformability between ring-stage infected cells and uninfected cells. The median velocity of
infected cells in the diverging geometry is 44% of that of the uninfected cells, compared to
80% in the converging geometry.
Deformability of reticulocytes contained in whole blood
Reticulocytes are immature RBCs and typically account for around 1% of RBCs in whole
blood. In contrast to mature RBCs, reticulocytes contain residual amounts of RNA. In our
experiments, we diluted whole blood in phosphate-buffered saline (PBS) containing thiazole
orange, a nucleic acid stain for reticulocytes. Then, the diluted blood was used directly in
our device, without any further pre-treatment. White blood cells are removed at the inlet
region of the device due to the 4.2 µm device height and filtration pillars and therefore do
not interfere with the operation of the device.
Reticulocytes are larger than mature RBCs, on average having 44 µm2 more surface area and
29 fL greater volume than mature RBCs 29. Additionally, reticulocytes are more rigid than
mature RBCs. Reticulocytes take a substantially longer time to enter a single pore 30, and
much higher pressure is necessary to bend the reticulocyte membrane and to force it to enter
a pipette 28. The membrane shear elastic modulus of reticulocytes is almost double that of
mature RBCs 31. In our experiments, reticulocytes exhibited velocity on average 67% that of
mature RBCs in the diverging geometry, and 61% that of mature RBCs in the converging
geometry (Figure 5).
Dissipative Particle Dynamics (DPD) simulation of cell deformation through different
constriction geometries
We performed three-dimensional simulations of uninfected and P. falciparum-infected cells
using the DPD method. Infected cells were modeled with increased shear modulus and
membrane viscosity values obtained from quantitative experimental measurements
performed by recourse to optical tweezers stretching of the parasitized RBCs 19. We
modeled the parasite as a rigid sphere, 2 microns in diameter 32, placed inside the cell
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(Figure 1C). Snapshots from simulations showing passage of an infected RBC through
channels with converging and diverging pore geometries are shown in Figure 1D.
Simulations were able to capture the effects of pore geometry and changes of RBC
properties arising from parasitization quite well. Quantitative comparison of simulation
results with experimental data for uninfected and infected cell velocity as a function of
applied pressure gradient is shown in Figure 6A and B.
In order to evaluate contributions of individual mechanical properties of the cell to overall
dynamic behavior, we performed additional simulations. The DPD model provides a unique
opportunity to perform this analysis, since experimental evaluation of these contributions is
laborious or impossible. We found that the flow behavior of infected RBCs in the device
was not affected by the presence of the parasite inside the cell (Figure 6C). Larger cells were
found to travel with lower velocities; however, the velocity variation due to cell size was not
significant (Figure 7A). Therefore, decrease of the traverse velocity of infected RBCs was
mainly due to the increase of membrane shear modulus and/or membrane viscosity.
Additional simulations were performed in which membrane shear modulus and membrane
viscosity were varied independently of each other. The results showed that shear modulus
was a dominant factor, while variation of membrane viscosity did not contribute
significantly to the decrease of velocity of infected cells.
Increased membrane viscosity should increase the time it takes for a RBC to traverse an
individual pore. However, it also slows down the recovery of RBC shape when the cell is
traveling between pores, making it easier to enter the next pore. As a result, the particular
design of our device lessens the dependence of the cell velocity on membrane viscosity
(Figure 7B). Increased membrane shear modulus increases the transit time for an individual
pore and also accelerates shape recovery, making it more difficult to enter the next pore. In
Figure 7C we plot the variation of time it takes a cell to travel from one set of obstacles to
the next at a pressure gradient of 0.24 Pa/µm as a function of membrane shear modulus. To a
first approximation, the time increases linearly with shear modulus within the range
considered in simulations. This simple dependence can be an advantage if the device is used
to estimate the average shear modulus of a cell population based on the average velocity.
For higher values of shear modulus, the transit time is likely to become a non-linear
function; however, stiffer cells (e.g. shear modulus greater than 30 µN/m, 19) are presumably
cleared by the spleen and therefore not typically present in free circulation.
Discussion
We have developed a versatile tool to measure cells’ deformability in a quantitative, high-
throughput manner, along with other optical (fluorescence) characteristics of the cells. We
applied our deformability cytometer to malaria research, by measuring dynamic
deformability of low-abundance (1–2%) ring-stage infected RBC population out of a much
larger number of uninfected RBCs. Common methods for assessing cell deformability
involve bulk measurements 3. Therefore bulk measurements do not offer the sensitivity
required to measure the mechanical properties of only the infected RBCs. Furthermore, bulk
measurements require relatively large volumes of precious cultured cells. Our device also
overcomes many of the limitations inherent in traditional single-cell measurements, such as
low throughput and measurement artifacts that decrease physiological relevance.
Additionally, diluted whole blood can be directly used in our device, without the need for
centrifugation or other separation steps. It is straightforward to combine our device with
other microfluidic methods to assess cell properties, such as the surface area-to-volume
measurement parallel microchannels33 and the oxygen perfusion-approach of Higgins et
al. 34.
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Quantitative measurement of dynamic cell deformability for various stages of P. falciparum-
infected RBCs (both asexual and sexual stages) and other types of blood cells would be
significant, both scientifically and clinically. P. falciparum-infected RBC deformability
could be used as a biophysical marker for enriching infected RBCs for improving the
sensitivity of microscopy-based malaria diagnostics35. In addition, dynamic deformability
measurement in this work essentially measures the cell’s susceptibility to the splenic
biofiltration process, which has a significant role in clearing both malaria parasites and other
bloodborne pathogens in general36.
In our results, deformability measurement of ring-stage P. falciparum infected RBCs and
uninfected RBCs shows significant overlap in terms of their dynamic deformability, even
though the average dynamic deformability (measured as the cell velocity) are clearly
different for the two populations. One confounding issue is the low abundance of infected
cells (typically less than 2%) compared with uninfected cells. This means that extreme
outliers of Gaussian-like cell velocity distribution of uninfected cells could still overwhelm
the minority population of infected RBCs in our measurement, which is a ubiquitous
problem in low-abundance detection. In addition, the normal RBC population is inherently
diverse, due to cells’ age and other factors 25. Because the spleen removes some of the older
RBCs and not all of the ring-stage P. falciparum-infected RBCs, as demonstrated by
Safeukui et al.7, it can be inferred that the rigidities of ring-stage P.falciparum-infected
RBCs and uninfected but older RBCs must overlap to some extent. We suspect that a rather
large distribution of deformability for the uninfected RBC population may come from this
diversity. When any single modality alone (e.g. cell deformability or cell surface marker
status) cannot be used due to its limited specificity, multi-modal analysis provide more
precise discrimination between different cell populations, as we have demonstrated. Our
ability to differentiate reticulocytes from P. falciparum-infected cells is an example of such a
multi-modal analysis. In Figures and 5, we observe that the velocities of reticulocytes and P.
falciparum-infected cells are similar compared to those of uninfected cells. As cell rigidity
alone cannot differentiate the two populations, staining with fluorescent dyes that
distinguish RNA and DNA content provides another level of resolution. Reticulocytes
contain uniformly dispersed RNA remnants and P. falciparum-infected cells contain
localized DNA within the parasite. Therefore, a combination of cell deformability and
fluorescence cytometry allows differentiation of these cell populations, and quantitative
measurement of their respective dynamic deformability properties. Additionally, the ability
of our deformability cytometer to clearly distinguish reticulocytes in a large population of
RBCs points to its potential for studying other human malarial parasites, such as
Plasmodium vivax malaria, which preferentially invades reticulocytes.
We have also shown experimentally, for the first time, that entrance geometry of the
constriction has a significant impact on RBC transit time, which has not been fully
appreciated before. We have also experimentally demonstrated that geometries with sharper
corners are better able to discriminate differences in RBC deformability for a given pressure
difference. Using this tool, we measured the dynamic deformability of ring-stage P.
falciparum-infected RBCs quantitatively and statistically significantly. Using the advanced
DPD modeling and simulation, it should be possible to further optimize the entrance
geometries for better selectivity of infected versus uninfected RBCs. Currently, there is
some disagreement regarding which aspect of pore traversal causes the distribution in
velocities. Brody et al. assert that pore entrance time is insignificant compared to kinetic
friction between the RBC membrane and device walls for differences in RBC velocity 20.
However, Secomb and Hsu propose that the time taken for RBCs to enter pores is more than
one half of the transit time for a single pore 37. In addition to the distribution in velocities,
the effect of the entrance shape on traversal time has not been experimentally examined.
Computational simulations examining the impact of entrance radius of curvature on the
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neutrophil transit time indicate that larger radii of curvature result in decreased transit
time 38. However, to the best of our knowledge, no controlled experimental studies have
been presented. In our experiments, we found that converging geometries resulted in RBCs
exhibiting faster velocities on average when moving through the channels. We also found
that an entrance geometry with a more abrupt transition from an open region to a pore is
better at discerning differences in RBC deformability, as shown by our experiments with
late ring-stage P. falciparum-infected RBCs. Whole blood is known to be a non-Newtonian
fluid, with viscosity decreasing with shear rate. However, in the context of our experiments,
this large-scale effect does not play a major role, since in our experiments the hematocrit
was approximately 1%, while it is between 33% and 49% in whole blood. What is relevant
in our experiments is the relaxation time of an individual RBC (approximately 0.2
seconds) 39. When an individual RBC does not have enough time to recover its original
shape before crossing from one constriction to the next, that RBC may assume a more
favorable shape upon encountering the second constriction. This more favorable shape may
then decrease the amount of time required for the RBC to deform and traverse the next pore
than what would be predicted had the RBC assumed its original shape. Computer
simulations by Shirai et al. of neutrophils passing through a succession of two cylindrically-
symmetrical pores showed reduced transit time through the second pore under certain flow
conditions 40. Groisman et al. applied this phenomenon in the context of polyacrylamide
polymers to create microfluidic flux stabilizers 41. When the RBC relaxation time is
substantially greater than the inter-pore travel time (e.g. at high pressure gradients), the
ability of our device to discriminate differences in rigidity will be diminished. More
generally, when the pore-traversal time is substantially shorter than the relaxation time of
the RBC, the sensitivity of the measurement to deformability may be compromised.
Therefore, we believe there is a maximum throughput for pore-based deformability
measurement methods.
The device that we present may be applicable to drug efficacy screening and cancer
diagnostics. In P. falciparum malaria, only ring-stage infected RBCs are found in the
circulation, while later-stage infected RBCs are either removed by the spleen (due to their
increased stiffness) or adhere to the vascular endothelium (due to their cytoadherent
properties). In fact, the subtle deformability increase of ring-stage infected RBCs and their
ability to pass through the spleen are critical for P. falciparum survival in an infected host.
One obvious and interesting application of this device would be screening for drug
compounds that increase ring-stage infected RBC rigidity to improve splenic clearance, or
decrease late-stage parasite infected RBC rigidity to prevent capillary blockage. It has also
been shown that primary cancer cells exhibit different deformabilities compared to normal
cells42. Often cells from primary tumors detach and circulate in the bloodstream. Although
the concentration of these circulating tumor cells (CTCs) is very low, we believe that with
appropriate pre-processing steps, our device may be able to further enrich for these CTCs
and aid in their detection. Overall, we believe the microfluidic deformability-based flow
cytometer will provide unexplored opportunities in drug efficacy screening and cancer
detection.
Materials and Methods
Device Fabrication
A mold of the device was made on a silicon wafer using photolithography and reactive-ion
etching techniques. A 5x reduction step-and-repeat projection stepper (Nikon NSR2005i9,
Nikon Precision) was used for patterning. The spacing between pillars was 3 µm, and the
depth of the device was 4.2 µm. Devices with other depths were also created, however those
with depths less than 3 µm resulted in RBCs not being able to satisfy their surface-area to
volume constraints and the device clogging up within minutes. Devices with depths greater
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than 5 µm resulted in RBCs not substantially deforming while passing through the pores,
which led to a loss of sensitivity. Details regarding the device structure are presented in
Figure 1A. The device was made using standard PDMS casting protocols and bonded to a
glass slide.
Parasite culture
P. falciparum was cultured in leukocyte-free human RBCs (Research Blood Components,
Brighton, MA) under an atmosphere of 5% O2, 5% CO2 and 95% N2, at 5% hematocrit in
RPMI culture medium 1640 (Gibco Life Technologies) supplemented with 25 mM HEPES
(Sigma), 200 mM hypoxanthyne (Sigma), 0.20% NaHCO3 (Sigma) and 0.25% Albumax II
(Gibco Life Technologies). Parasites were synchronized by treatment with 5% sorbitol at
least 12 hours before sample collection. The strain FUP-GFP, expressing a GFPmut2-neo
fusion protein, was constructed by transfecting P. falciparum strain FUP with the plasmid
pFGNr (Malaria Research and Reference Reagent Resource Center). Parasites expressing
GFPm2:neo were selected with 350 mg/L G-418. Transfection was performed by the
spontaneous DNA uptake method 43.
Experimental Protocol
PBS was mixed with 0.2 % w/v Pluronic F-108 (BASF, Mount Olive, NJ) and 1 % w/v
Bovine Serum Albumin (BSA) (Sigma-Aldrich, St. Louis, MO) as a stock solution to
prevent RBC adhesion to the device walls. This was the stock solution used in all of the
experiments. For the fluorescent bead experiments, 200 nm FluoSpheres europium
luminescent microspheres (Molecular Probes, Eugene, OR) diluted to a final concentration
of 1.25×10−5 percent solids were used.
In experiments involving blood, 1 µl of whole blood (~50% hematocrit) was diluted in 100
µl of the PBS-pluronic-BSA solution for all of the experiments. In experiments involving
parasites that express GFP, no further treatment was performed. These cells appear as
shadows with a small fluorescent circle inside, as shown in Figure 1B. In experiments
involving uninfected RBCs, 1 µl of whole blood (Research Blood Components, Brighton,
MA), 1 µl of 50 µg/ml of Cell Tracker Orange (Invitrogen, Carlsbad, CA), and 98 µl of PBS
were mixed with the indicated concentration of glutaraldehyde and allowed to sit for 30
minutes. The sample was then washed 3 times with the PBS-Pluronic-BSA solution. In
experiments involving reticulocytes, 1 µl of whole blood, 89 µl of the PBS-Pluronic-BSA
solution, and 10 µl of 1×10−6 M thiazole orange were mixed and allowed to sit for 20
minutes before starting experiments. In our videos, reticulocytes appear as uniformly
fluorescent cells under the GFP filter set, while mature RBCs appear as shadows.
The PBS-Pluronic-BSA solution was pumped through the device for 30 minutes to coat the
device walls with Pluronic and BSA. The RBC-PBS-Pluronic-BSA suspension was then
injected into the device. Differences in pressure between the two reservoirs were generated
hydrostatically by a difference in water column height. Liquid columns were connected to
60-ml plastic syringes lacking plungers to minimize surface tension effects. A Hamamatsu
Model C4742-80-12AG CCD camera (Hamamatsu Photonics, Japan), connected to an
inverted epi-fluorescent Olympus IX71 microscope (Olympus, Center Valley, PA) was used
for imaging. IPLab (Scanalytics, Rockville, MD) was used for video acquisition, resulting in
an .avi file.
Data Analysis
A custom-written MATLAB program tracked the RBCs and generated data used for velocity
histograms. This program first applies a high-pass filter to the video frames and then
identifies RBCs based on areas of intensity above a certain threshold and within a preset
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size. After identifying the RBCs in a particular frame, it first attempts to match the RBCs in
the current frame to RBCs in the previous frame based on proximity. The program then
takes the location and velocity of RBCs in the previous frame to confirm the match to RBCs
in the current frame. The end result of this program is a video with RBCs identified by
number and a spreadsheet of each RBC’s velocity. The video was then checked for RBC
identification accuracy.
Simulation Setup
The Dissipative particle dynamics (DPD)44 method was employed in simulations. In DPD,
the fluid, solid walls, and RBC membrane are represented by collections of particles. The
particles interact with each other through soft pairwise forces: conservative, dissipative, and
random force. The latter two form the DPD thermostat and are linked through the
fluctuation-dissipation theorem. The viscosity of the DPD fluid can be varied by changing
the functional form and magnitude of these forces45. The solid walls were assembled from
randomly distributed DPD particles whose positions were fixed during the simulations. In
addition, bounce-back reflections were used to achieve no-slip conditions and prevent fluid
particles from penetrating the walls46. A portion of the microfluidic device with dimensions
200 by 120 by 4.2 microns containing 5 rows of pillars (10 pillars in each row) was
modeled. The fluid region was bounded by four walls while periodic boundary conditions
were used in the flow direction. The RBC was simulated using 5000 DPD particles
connected with links47. The model took into account bending, in-plane shear energy, and
membrane viscosity. The effect of membrane viscosity was modeled by adding frictional
resistance to each link. The total area and volume were controlled through additional
constraints. Parameters of the uninfected cell model were derived from RBC spectrin
network properties47–49. In addition, membrane fluctuation measurements and optical
tweezers experiments were used to define simulation parameters. Specifically, we required
that the amplitude of thermal fluctuations of the membrane at rest to be within the range of
experimental observations50. We also required that the characteristic relaxation time of the
RBC model in simulations to be equal to the experimentally measured value of 0.18
seconds. For P. falciparum infected cells, the membrane shear modulus and viscosity were
increased 2.5 times19. The P. falciparum parasite was modeled as a rigid sphere, 2 microns
in diameter. The RBC model was immersed into the DPD fluid. The membrane particles
interacted with internal and external fluid particles through the DPD forces. The viscosity of
the internal fluid was 9 times higher than external fluid viscosity. The flow was sustained by
applying a body force to the DPD particles. By changing the direction of the body force, the
motion of the cell through channels with converging and diverging pores was simulated
using the same channel geometry.
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Figure 1.
A. Illustration of device design; each channel of the actual device is 10 pores wide and 200
pores long. B. Experimental images of ring-stage P. falciparum-infected (red arrows) and
uninfected (blue arrows) RBCs in the channels at a pressure gradient of 0.24 Pa/µm. The
small fluorescent dot inside the infected cell is the GFP-transfected parasite. At 8.3 s, it is
clear that the uninfected cell moved about twice as far as each infected cell. C. The
computational RBC model consists of 5000 particles connected with links. The P.
falciparum parasite is modeled as a rigid sphere inside the cell. D. DPD simulation images
of P. falciparum-infected RBCs traveling in channels of converging (left) and diverging
(right) pore geometry at 0.48 Pa/µm.
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Figure 2.
A. Velocity of individual 200-nm-diameter beads at a pressure difference of 0.49 Pa/µm.
There is no statistically significant difference in the velocity of beads travelling through the
converging and diverging geometries. The beads travelling through the channel with
rectangular obstacles move slower on average. B. Velocity vs. Pressure for the different
obstacle geometries.
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Figure 3.
A Velocity vs. pressure for RBCs moving through the two pore geometries. Error bars
indicate standard deviation for each measurement. B. Velocity vs. glutaraldehyde
concentration (v/v). RBCs were treated with the indicated concentration of glutaraldehyde
for 30 minutes in PBS and then washed 3 times. The pressure difference/length was
approximately 0.61 Pa/µm.
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Figure 4.
A. FACS-like plot of velocity vs. intensity for ring-stage P. falciparum infected RBCs at a
pressure gradient of 0.24 Pa/µm travelling in the converging geometry. Points to the right of
the vertical line represent velocities of infected RBCs, while those to the left represent
velocities of uninfected RBCs. The velocities of 381 RBCs were tracked. B. Velocity vs.
infection state for RBCs infected with late ring-stage parasites at a pressure gradient of 0.24
Pa/µm. For each infected cell that was tracked, the next uninfected cell was tracked. Twenty
cells were tracked for each measurement.
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Figure 5.
Velocity vs. cell maturation state. All experiments were run simultaneously, at a pressure
gradient of 0.24 Pa/µm. Whole blood RBCs was stained for nucleic acid content with
thiazole orange. Cells homogeneously fluorescesing under the GFP filter set were identified
as reticulocytes. For every reticulocyte that was identified and tracked for 200 µm, the next
cell appearing in the field of view was also tracked.
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Figure 6.
A. Velocity vs. pressure for uninfected and ring-stage-infected RBCs in diverging pore
geometry: comparison of simulation and experimental results. For experimental data, mean
values are shown. The error bars correspond to one standard deviation. B. Velocity vs.
pressure in converging pore geometry. C. Effect of intracellular parasite presence on the
velocity of ring-stage infected cells. The parasite is modeled in simulations as a rigid sphere,
2 microns in diameter, placed inside the cell.
Bow et al. Page 18
Lab Chip. Author manuscript; available in PMC 2012 June 04.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7.
Dissipative particle dynamics (DPD) simulations. A. Effect of RBC size variation on transit
time at a pressure gradient of 0.24 Pa/µm. Cells with surface area of 125, 135 and 145 µm2
are modeled with corresponding volumes of 85, 94 and 103 µm3. B. Effect of membrane
viscosity variation on RBC transit time at a pressure gradient of 0.24 Pa/µm. The membrane
viscosity is normalized by the uninfected cell membrane viscosity value. C. RBC transit
time vs. membrane shear modulus at 0.24 Pa/µm.
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